Home LiteratureArticle Details
PMID: 6903572 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.

The Journal of clinical investigation ·Vol. 66 ·No. 5 ·1980-11-00 ·Pages 1094-100

Kita T, Brown MS, Goldstein JL

Abstract

Compactin (ML-236B) and the related compound, mevinolin, are competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase), the rate-controlling enzyme in cholesterol synthesis. Previous studies have shown that administration of compactin to cultured cells elicits a compensatory increase in the amount of HMG CoA reductase in the cells. A similar increase in HMG CoA reductase has been reported in livers of rats and mice that have been treated with compactin. In this study, we explore the mechanism for the mevinolin-mediated increase in hepatic HMG CoA reductase in mice that have been fed a control diet and a 2% cholesterol diet. Administration of mevinolin to mice on a control diet produced a 6- to 10-fold increase in the amount of HMG CoA reductase in liver microsomes. When mice were fed the cholesterol-enriched diet, cholesterol accumulated in the liver and HMG CoA reductase declined by 90%. The administration of mevinolin to cholesterol-fed mice produced a three to eightfold increase in HMG CoA reductase. Despite the abundant amount of cholesterol that was already present in the livers of the mevinolin-treated, cholesterol-fed animals, their elevated HMG CoA reductase could be rapidly suppressed by the subcutaneous injection of small amounts of mevalonate, the product of HMG CoA reductase. These data are compatible with the existence in mouse liver of a multivalent feedback regulatory mechanism for HMG CoA reductase in which suppression of the enzyme requires both a sterol and a nonsterol substance derived from mevalonate. By blocking mevalonate synthesis, mevinolin activates this regulatory mechanism, and this in turn causes an increase in hepatic HMG CoA reductase. The ability to suppress the elevated HMG CoA reductase with mevalonate may prove useful in potentiating the effectiveness of mevinolin as a hypocholesterolemic agent.

MeSH Terms
Alkaline Phosphatase/pharmacology Animals Cholesterol/metabolism Cholesterol, Dietary/administration & dosage Dose-Response Relationship, Drug Feedback Hydroxymethylglutaryl CoA Reductases/metabolism Hydroxymethylglutaryl-CoA Reductase Inhibitors Liver/drug effects,enzymology Lovastatin Male Mevalonic Acid/pharmacology Mice Naphthalenes/pharmacology
Chemicals
Cholesterol, Dietary Hydroxymethylglutaryl-CoA Reductase Inhibitors Naphthalenes Cholesterol Lovastatin Hydroxymethylglutaryl CoA Reductases Alkaline Phosphatase Mevalonic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kita T
Brown M S
Goldstein J L
References (18)
18 references, click to expand
  1. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.
    J Clin Invest. 1975 Apr;55(4):783-93 PMID: 164482
  2. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum.
    J Chem Soc Perkin 1. 1976;(11):1165-70 PMID: 945291
  3. Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo.
    J Biol Chem. 1977 Feb 10;252(3):1057-63 PMID: 14128
  4. Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase.
    J Biol Chem. 1977 Dec 25;252(24):8924-34 PMID: 925031
  5. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.
    J Biol Chem. 1978 Feb 25;253(4):1121-8 PMID: 624722
  6. Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
    Eur J Biochem. 1978 Jun 15;87(2):313-21 PMID: 668696
  7. 3-Hydroxy-3-methylglutaryl coenzyme A reductase: regulation of enzymatic activity by phosphorylation and dephosphorylation.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):3678-82 PMID: 278983
  8. Reversible modulation of liver hydroxymethylglutaryl CoA reductase.
    Life Sci. 1978 Dec 31;23(27-28):2649-64 PMID: 216867
  9. Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states.
    J Biol Chem. 1979 Jun 25;254(12):5144-9 PMID: 376507
  10. Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.
    J Biol Chem. 1979 Jun 25;254(12):5403-9 PMID: 221469
  11. Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Lipids. 1979 Jun;14(6):585-9 PMID: 110993
  12. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.
    J Antibiot (Tokyo). 1979 Aug;32(8):852-4 PMID: 500505
  13. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals.
    Biochim Biophys Acta. 1979 Nov 21;575(2):266-76 PMID: 508786
  14. Therapeutic effects of ML-236B in primary hypercholesterolemia.
    Atherosclerosis. 1980 Mar;35(3):259-66 PMID: 7362699
  15. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.
    J Lipid Res. 1980 Jul;21(5):505-17 PMID: 6995544
  16. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):3957-61 PMID: 6933445
  17. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  18. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
    FEBS Lett. 1976 Dec 31;72(2):323-6 PMID: 16386050
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1980-11-00
Pages
1094-100
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC371547
Subset
IM
Grants
NHLBI NIH HHS · HL-20948 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]